Web Analytics

Agonistic immune checkpoint regulator may harm the heart



Agonistic immune checkpoint regulator may harm the heart



Summary

Agonistic immune checkpoint regulators (AICRs), designed to enhance anti-tumor immunity, may pose a risk to the heart. While AICRs like CD40 agonists are showing promise in cancer treatment by boosting T cell activity, studies indicate they can trigger unintended inflammation in the cardiovascular system. This inflammation can lead to myocarditis, heart failure, and other cardiac complications. This highlights the need for careful monitoring of cardiac function in patients receiving AICR therapy, and further research to understand and mitigate these potential cardiotoxic effects, ensuring safer and more effective cancer immunotherapy.

Read more…

Credits: Source

This post is part of “Science/Immunology News”, Follow for more…!!!


Discover more from abdullahfarhan.com

Subscribe to get the latest posts sent to your email.

Dr AF Saeed

Related post

Thank you for Visiting. Leave a Reply!

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.